PMID- 35931991 OWN - NLM STAT- MEDLINE DCOM- 20220809 LR - 20220809 IS - 2731-4553 (Electronic) IS - 2731-4553 (Linking) VI - 23 IP - 1 DP - 2022 Aug 5 TI - The effectiveness of a mHealth-based integrated hospital-community-home program for people with type 2 diabetes in transitional care: a protocol for a multicenter pragmatic randomized controlled trial. PG - 196 LID - 10.1186/s12875-022-01814-8 [doi] LID - 196 AB - BACKGROUND: Diabetes is a progressive condition requiring long-term medical care and self-management. The ineffective transition from hospital to community or home health care may result in poor glycemic control and increase the risk of serious diabetes-related complications. In China, the most common transitional care model is home visits or telephone interventions led by a single healthcare setting, with a lack of cooperation between specialists and primary care, which leads to inadequate service and discontinuous care. Thus, an integrated hospital-community-home (i-HCH) transitional care program was developed to promote hospital and community cooperation and provide comprehensive and continuous medical care for type 2 diabetes mellitus (T2DM) via mobile health (mHealth) technology. METHODS: This protocol is for a multicenter randomized controlled trial in T2DM patients. Hospitalized patients diagnosed with T2DM who meet the eligibility criteria will be recruited. The patients will be randomly allocated to either the intervention or the control group and receive the i-HCH transitional care or usual transitional care intervention. The change in glycated hemoglobin is the primary outcome. Secondary outcome measures are blood pressure, lipids (total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein), body mass index, self-management skills, quality of life, diabetes knowledge, transitional care satisfaction and the rate of readmission. The follow-up period of this study is six months. DISCUSSION: The study will enhance the cooperation between local hospitals and communities for diabetes transitional care. Research on the effectiveness of diabetes outcomes will have potentially significant implications for chronic disease patients, family members, health caregivers and policymakers. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900023861: June 15, 2019. CI - (c) 2022. The Author(s). FAU - Zhang, Wenhui AU - Zhang W AD - Nursing Department, Gongli Hospital, Pudong, Shanghai, China. AD - The School of Nursing, Ningxia Medical University, Yinchuan, Ningxia, China. FAU - Yang, Pei AU - Yang P AD - The School of Nursing, Ningxia Medical University, Yinchuan, Ningxia, China. FAU - Wang, Hongyan AU - Wang H AD - Nursing Department, Gongli Hospital, Pudong, Shanghai, China. FAU - Pan, Xinxin AU - Pan X AD - Nursing Department, Gongli Hospital, Pudong, Shanghai, China. FAU - Wang, Yanmei AU - Wang Y AUID- ORCID: 0000-0001-7773-3470 AD - Nursing Department, Gongli Hospital, Pudong, Shanghai, China. tg20212021@126.com. LA - eng SI - ChiCTR/ChiCTR1900023861 PT - Clinical Trial Protocol PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220805 PL - England TA - BMC Prim Care JT - BMC primary care JID - 9918300889006676 SB - IM MH - *Diabetes Mellitus, Type 2/therapy MH - Hospitals MH - Humans MH - Multicenter Studies as Topic MH - Quality of Life MH - Randomized Controlled Trials as Topic MH - *Telemedicine/methods MH - *Transitional Care PMC - PMC9356450 OTO - NOTNLM OT - Apps OT - Mobile health OT - Self-management OT - Smartphone applications OT - Transitional care OT - Type 2 diabetes COIS- No competing interests. EDAT- 2022/08/06 06:00 MHDA- 2022/08/10 06:00 PMCR- 2022/08/05 CRDT- 2022/08/05 23:35 PHST- 2021/09/22 00:00 [received] PHST- 2022/07/29 00:00 [accepted] PHST- 2022/08/05 23:35 [entrez] PHST- 2022/08/06 06:00 [pubmed] PHST- 2022/08/10 06:00 [medline] PHST- 2022/08/05 00:00 [pmc-release] AID - 10.1186/s12875-022-01814-8 [pii] AID - 1814 [pii] AID - 10.1186/s12875-022-01814-8 [doi] PST - epublish SO - BMC Prim Care. 2022 Aug 5;23(1):196. doi: 10.1186/s12875-022-01814-8.